Topoisomerase inhibitor, Levofloxacin hydrate, Purity ≥98%

Synonym: 138199-71-0; Levofloxacin hemihydrate; Levaquin hydrate; Tavanic hydrate; Quixin hydrate; Iquix hydrate; Cravit hydrate; (2S)-7-Fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid; hydrate

MDL: MFCD07772024
CAS Number: 138199-71-0
Compound CID: 3033924

Product Size

100 mg; 200 mg; 500 mg; 1000 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

Levofloxacin hydrate, soluble in DMSO, water and ethanol, is an effective DNA damage inhibitor, that has the ability to prevent the pathway of DNA damage by inhibiting topoisomerase.

Molecular Weight

370.38

Molecular Formula

C₁₈H₂₀FN₃O₄·1/2H₂O

Form

Lyophilized powder

Purity

≥98%

Titer

Free from inappropriate visible particulates, foreign matter, discoloration, or other defects

Solubility

In vitro: DMSO: 69 mg/mL (186.29 mM); Water: 5 mg/mL (13.49 mM); Ethanol: 9 mg/mL (24.29 mM)

Stability

In its lyophilized form, the chemical remains stable for 36 months.

Quality Level

Research grade

Applications

Levofloxacin hydrate is a DNA damage inhibitor that can be used for its anticancer effects.

Storage

Store at -20ºC, and keep desiccated.